Abstract Background Cystic fibrosis (CF) lung disease is characterised by vigorous airway inflammation eventually resulting in severe lung damage. This study aimed to describe the diversity of the inflammatory pattern in end-stage CF lungs by evaluating and quantifying which components of the innate and adaptive immunity are involved, and by assessing whether this is gender-specific. Methods CF explant lung tissue ( n \u2009=\u200920) collected at time of transplantation and control tissue ( n \u2009=\u200922) was sectioned (9\ua0\u3bcm) and stained for neutrophils, eosinophils, mast cells, dendritic ce...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
Background: Cystic fibrosis (CF) lung disease is characterised by vigorous airway inflammation event...
Background: Cystic fibrosis (CF) lung disease is characterised by vigorous airway inflammation event...
Airway inflammation represents a hallmark of the cystic fibrosis (CF) disease. However, the mucosal ...
BACKGROUND: Airway inflammation and infection are early events in cystic fibrosis (CF) pathogenesis....
Cystic fibrosis (CF) is the most common life-limiting single-gene disease. It is caused by mutations...
Background: Primary defects in host immune responses have been hypothesised to contribute towards an...
AbstractChronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients...
Cystic fibrosis (CF) is caused by mutations to the CF transmembraneconductance regulator (CFTR) gene...
Chronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pu...
AbstractThe pathological hallmark of cystic fibrosis (CF) chronic inflammatory response is the massi...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
Background: Cystic fibrosis (CF) lung disease is characterised by vigorous airway inflammation event...
Background: Cystic fibrosis (CF) lung disease is characterised by vigorous airway inflammation event...
Airway inflammation represents a hallmark of the cystic fibrosis (CF) disease. However, the mucosal ...
BACKGROUND: Airway inflammation and infection are early events in cystic fibrosis (CF) pathogenesis....
Cystic fibrosis (CF) is the most common life-limiting single-gene disease. It is caused by mutations...
Background: Primary defects in host immune responses have been hypothesised to contribute towards an...
AbstractChronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients...
Cystic fibrosis (CF) is caused by mutations to the CF transmembraneconductance regulator (CFTR) gene...
Chronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pu...
AbstractThe pathological hallmark of cystic fibrosis (CF) chronic inflammatory response is the massi...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...
BackgroundIn chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibit...